Prevention of diabetic renal disease with special reference to microalbuminuria (Q40415958)

20 September 2017

1 reference

title

Prevention of diabetic renal disease with special reference to microalbuminuria (English)

1 reference

20 September 2017

1 reference

C E Mogensen

1

1 reference

20 September 2017

W F Keane

2

1 reference

20 September 2017

P H Bennett

3

1 reference

20 September 2017

G Jerums

4

1 reference

20 September 2017

H H Parving

5

1 reference

20 September 2017

P Passa

6

1 reference

20 September 2017

M W Steffes

7

1 reference

20 September 2017

G E Striker

8

1 reference

20 September 2017

G C Viberti

9

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

20 September 2017

5

1 reference

inferred from page(s)

published in

The Lancet

1 reference

20 September 2017

346

1 reference

20 September 2017

1080-1084

1 reference

20 September 2017

8982

1 reference

Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. American Diabetes Association and the National Kidney Foundation

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney F

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Microalbuminuria predicts mortality in non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Microalbuminuria as predictor of increased mortality in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Microalbuminuria: an important warning sign from the laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Microalbuminuria: an important diagnostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Increased urinary albumin-excretion rate in benign essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Microalbuminuria as a predictor of clinical diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Screening for early diabetic nephropathy: which sample to detect microalbuminuria?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Screening for early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

First morning urinary albumin concentration is a good predictor of 24-hour urinary albumin excretion in children with type 1 (insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Management of early nephropathy in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Evaluation of a new semiquantitative stix for microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Renoprotective role of ACE inhibitors in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Normoalbuminuria ensures no reduction of renal function in type 1 (insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Renal function changes in middle-aged and elderly Caucasian type 2 (non-insulin-dependent) diabetic patients--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Progressive decline in renal function in diabetic patients with and without albuminuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Blood glucose control and microvascular complications--what do we do now?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

The use of antihypertensive agents in prevention and treatment of diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease--reproducibility, progression, and efficacy of antihypertensive intervention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Central role of sodium in hypertension in diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

A glycemic threshold for diabetic complications?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Improved survival in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Prognosis in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

Diabetic renal disease: the quest for normotension--and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2991747-0

7 January 2021

10.1016/S0140-6736(95)91747-0

Identifiers

DOI

1 reference

20 September 2017

1 reference